1. Atherogenic lipoprotein(A) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation. (December 2020) Authors: Schnitzler, J.G.; Hoogeveen, R.M.; Ali, L.; Prange, K.; Weeghel, M.V.; Versloot, M.; Waissi, F.; Houtkooper, R.; De Kleijn, D.P.V.; De Winther, M.; Koschinsky, M.; Tsimikas, S.; Witztum, J.L.; Stroes, E.; Kroon, J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of APOA1, ABCA1 and LCAT mutations on monocyte activation in humans – a double edged sword. (December 2020) Authors: Pavanello, C.; Zheng, K.H.; Schnitzler, J.G.; Kroon, J.; Versloot, M.; Levels, J.H.; Van Tuijl, J.; Riksen, N.P.; Stroes, E.; Calabresi, L.; Bekkering, S. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Elevated lipoprotein(a) levels increase risk of secondary major adverse cardiovascular events in patients undergoing carotid endarterectomy. (December 2020) Authors: Waissi, F.; Timmerman, N.; Dekker, M.; Hoogeveen, R.M.; Schnitzler, J.G.; De Borst, G.J.; Stroes, E.; De Kleijn, D.P.V.; Kroon, J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy. (August 2022) Authors: Verwer, M.C.; Waissi, F.; Mekke, J.M.; Dekker, M.; Stroes, E.S.; De Borst, G.J.; Kroon, J.; Hazenberg, C.E.V.B.; De Kleijn, D.P.V. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High plasma lipoprotein lipase is associated with a lower risk for future major adverse cardiovascular events in patients following carotid endarterectomy. (August 2022) Authors: Mekke, J.M.; Verwer, M.C.; Stroes, E.S.; Kroon, J.; Timmers, L.; Pasterkamp, G.; De Borst, G.J.; Van Der Laan, S.W.; De Kleijn, D.P.V. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hypercholesterolemia disrupts the metabolic regulation of hematopoietic stem cell behavior, favoring the production of pro-inflammatory monocytes in patients with familial hypercholesterolemia. (December 2020) Authors: Stiekema, L.C.A.; Willemsen, L.; Prange, K.; De Winther, M.; Voermans, C.; Stroes, E.; Kroon, J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of the key molecular events triggered by lipoprotein (a) in peripheral monocytes. (August 2018) Authors: Bahjat, M.; Nicorescu, I.; Hoogeveen, R.; Bekkering, S.; Kroon, J.; Stroes, E. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Increased arterial wall inflammation in patients with familial dysbetalipoproteinemia. (September 2016) Authors: Verweij, S.; Moens, S. Bernelot; Kroon, J.; Schnitzler, J.; Stroes, E. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Investigating the oxidative stress epitope malondialdehyde in myocardial ischemia reperfusion injury in a 2D and 3D heart-on-chip setting. (August 2022) Authors: Peletier, M.C.; Dzobo, K.E.; Kroon, J. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ldl-Cholesterol Lowering Treatment Changes Hematopoietic Stem Cell Behavior In Familial Hypercholesterolemia Patients. (August 2019) Authors: Stiekema, L.; Zeerleder, S.S.; Homburg, C.H.; Voermans, C.; Stroes, E.S.G.; Kroon, J. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗